Flash FinanceUS
Market closed · weekend S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026

IQVIA (IQV)

NYSE Health Care Life Sciences Tools & Services S&P 500
$271.83
+6.95 (+2.62%)
Close of Nov 06, 2026 · end-of-day data
Source: IQVIA's 10-K / 10-Q XBRL data on SEC EDGAR · fetched Nov 04, 2026

Revenue, net income & free cash flow

Income statement

fiscal years · USD
Fiscal yearFY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue$6.82B$9.70B$10.41B$11.09B$11.36B$13.87B$14.41B$14.98B$15.40B$16.31B
Cost of revenue—$6.30B$6.75B$7.30B$7.50B$9.23B$9.38B$9.74B$10.03B$10.88B
Gross profit—$3.40B$3.67B$3.79B$3.86B$4.64B$5.03B$5.24B$5.38B$5.43B
Selling, general & admin$1.02B$1.62B$1.72B$1.73B$1.79B$1.96B$2.07B$2.05B$1.99B$2.00B
Operating income$576.00M$665.00M$741.00M$777.00M$731.00M$1.39B$1.80B$1.98B$2.20B$2.18B
Interest expense$144.00M$346.00M$414.00M$447.00M$416.00M$375.00M$416.00M$672.00M$670.00M$729.00M
Pre-tax income$416.00M$294.00M$328.00M$352.00M$373.00M$1.13B$1.36B$1.46B$1.67B$1.59B
Income tax$325.00M-$992.00M$59.00M$116.00M$72.00M$163.00M$260.00M$101.00M$301.00M$252.00M
Net income$72.00M$1.28B$259.00M$191.00M$279.00M$966.00M$1.09B$1.36B$1.37B$1.36B
EBITDA$865.00M$1.68B$1.88B$1.98B$2.02B$2.66B$2.93B$3.10B$3.32B$3.33B
EPS (basic)$0.48$5.86$1.27$0.98$1.46$5.05$5.82$7.39$7.57$7.91
EPS (diluted)$0.47$5.74$1.24$0.96$1.43$4.95$5.72$7.29$7.49$7.84
Diluted shares152.00M222.60M208.20M199.60M195.00M195.00M190.60M186.30M183.40M173.50M
Gross margin—35.1%35.2%34.2%34.0%33.5%34.9%35.0%34.9%33.3%
Operating margin8.5%6.9%7.1%7.0%6.4%10.0%12.5%13.2%14.3%13.4%
Net margin1.1%13.2%2.5%1.7%2.5%7.0%7.6%9.1%8.9%8.3%

Balance sheet

fiscal years · USD
Fiscal yearFY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash & equivalents$1.20B$959.00M$891.00M$837.00M$1.81B$1.37B$1.22B$1.38B$1.70B$1.98B
Short-term investments$40.00M$46.00M$47.00M$62.00M$88.00M$111.00M$93.00M$120.00M$141.00M$161.00M
Receivables$1.71B$2.10B$2.39B$2.58B$2.41B$2.55B$2.92B$3.38B$3.20B$3.40B
Total current assets$3.34B$3.55B$3.87B$4.13B$5.09B$4.76B$4.98B$5.60B$5.83B$6.25B
Goodwill$10.73B$11.85B$11.80B$12.16B$12.65B$13.30B$13.92B$14.57B$14.71B$16.62B
Total assets$21.21B$22.86B$22.55B$23.25B$24.56B$24.69B$25.34B$26.68B$26.90B$29.94B
Total current liabilities$2.71B$3.16B$3.53B$3.94B$4.56B$5.24B$5.58B$6.49B$6.96B$8.34B
Short-term debt$92.00M$103.00M$100.00M$100.00M$149.00M$91.00M$152.00M$718.00M$1.15B$1.84B
Long-term debt$7.11B$10.12B$10.91B$11.54B$12.38B$12.03B$12.60B$12.96B$12.84B$13.88B
Total debt$7.20B$10.22B$11.01B$11.64B$12.53B$12.12B$12.75B$13.67B$13.98B$15.72B
Total liabilities$12.35B$14.61B$15.60B$16.99B$18.28B$18.65B$19.57B$20.57B$20.83B$23.31B
Shareholders' equity$8.63B$8.00B$6.71B$6.00B$6.00B$6.04B$5.76B$6.11B$6.07B$6.50B

Cash flow

fiscal years · USD
Fiscal yearFY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow$860.00M$970.00M$1.25B$1.42B$1.96B$2.94B$2.26B$2.15B$2.72B$2.65B
Capital expenditures$164.00M$369.00M$459.00M$582.00M$616.00M$640.00M$674.00M$649.00M$602.00M$603.00M
Free cash flow$696.00M$601.00M$795.00M$835.00M$1.34B$2.30B$1.59B$1.50B$2.11B$2.05B
Investing cash flow$1.73B-$1.19B-$810.00M-$1.19B-$796.00M-$2.10B-$2.01B-$1.60B-$1.44B-$2.31B
Financing cash flow-$2.28B-$72.00M-$452.00M-$276.00M-$217.00M-$1.24B-$329.00M-$382.00M-$878.00M-$150.00M
Share buybacks$1.10B$2.62B$1.41B$949.00M$447.00M$406.00M$1.17B$992.00M$1.35B$1.24B
Stock-based compensation$106.00M$106.00M$113.00M$146.00M$95.00M$170.00M$194.00M$217.00M$206.00M$247.00M
Depreciation & amortization$289.00M$1.01B$1.14B$1.20B$1.29B$1.26B$1.13B$1.12B$1.11B$1.14B

Quarterly figures are rebuilt from the year-to-date totals companies report — Q4 is the full year minus the first nine months, since no 10-Q is filed for it. Values are as filed; later restatements replace earlier ones. Fiscal years are labelled by the calendar year in which they end.